As Seen In:

Lilly HSA Plan Changes – Effective October 3, 2017

on .

hsa-health-savings-account

Lilly has recently announced changes to the investment menu within the Health Savings Account (HSA). Effective October 3, 2017, all funds are moving from Class A to Institutional Class Shares. This will not be a change in the actual funds or underlying investments, but the fund ticker symbols will be different and fees will be lower. You will automatically be moved to the new investments on October 2. No action is required on your part.

If you have automated investing set up on your HSA, those instructions will automatically be transferred to the new Institutional Class shares of the same fund(s). No action is required on your part.

In addition, as of September 25, 2017, new investments into Dreyfus Premier Strategic Value (DAGVX.LW) and Dreyfus Appreciation Fund (DGAGX) will no longer be allowed. These funds are being eliminated from the HSA, however, if you currently invest in these funds, you may continue to hold the investments or move them to a new fund at any time.

Gabelli Asset Fund has a short-term trading fee. New investments in Class A shares will be blocked beginning September 22 to help participants avoid being subject to this fee. The Institutional Class Shares will re-open for new investments on October 3. Any automated investing scheduled during this blocked period will be executed on October 3.

Three new index funds will be added. Vanguard Mid Cap Index (VIMAX), Vanguard Total International Stock Index (VTIAX) and Vanguard Total Bond Market Index (VBTLX).

If you have questions regarding how these changes may affect your HSA portfolio, please do not hesitate to contact Oaktree toll-free at 877-901-1631 or info@oaktreeadvisors.com

Oaktree Financial Advisors is neither endorsed by or affiliated with Eli Lilly. The information contained herein is provided for informational purposes only and is based upon sources believed to be reliable. No guarantee is made to the completeness or accuracy of the information. This content should not be construed as investment advice, a solicitation, or recommendation to buy any security or investment product. Contact your financial professional regarding your specific circumstances.

Please consider the investment objectives, risks, charges, and expenses carefully before investing. The prospectus, which contains this and other information about the mutual fund, can be obtained from your financial professional. Be sure to read the prospectus carefully before deciding whether to invest.